A 6-year-old with a significant past medical history of asthma is rushed to the emergency department at midnight after experiencing a cyanotic spell.
FDA grants Priority Review to pitolisant for pediatric narcolepsy patients
A Prescription Drug User Fee Act (PDUFA) target action date of June 21, 2024, has been set by the FDA.
Food Insecurity and the Dangers of Infant Formula Dilution
Neffy epinephrine nasal spray demonstrates positive data in repeat dosing study
ARS Pharma plans to submit data from the repeat dose study of neffy to the FDA early in the second quarter of 2024, as part of its response to the CRL issued by the federal agency for the previously submitted New Drug Application (NDA).
Demystifying Infant Formula
Identifying arrhythmias in children using smartwatch technology
How effective can wearable technology with features designed for adults be for children when it comes to arrhythmias? Scott Ceresnak, MD, helps provide the answer in this Contemporary Pediatrics interview.
Iron deficiency associated with hearing loss risk in adolescents
Microalbuminuria and low body iron levels displayed a significant association with pediatric hearing loss independently.
2 Commerce Drive Cranbury, NJ 08512